中国肝细胞腺瘤基因型-表型分类的MR成像研究
该回顾性研究纳入36例患者共39个病理证实的肝细胞腺瘤,行钆喷酸葡胺增强MRI,比较四种亚型的形态与影像特征。结果显示T1、T2信号、强化方式、病灶异质性及伴随征象在亚型间存在差异(P<.0001至P=.019),ADC值整体在亚型间不同(P=.029),β-catenin突变型ADC最低,但事后比较无显著差异(P=.066-1.000)。
要点
- 中国肝细胞腺瘤患者中男性占52.8%,均无口服避孕药史,16.7%合并乙肝感染。
- T1、T2信号、强化方式、病灶异质性及脂肪变、坏死、中央瘢痕、假包膜在亚型间有差异。
- ADC值在亚型间整体不同(P=.029),β-catenin突变型ADC最低,但事后比较无显著差异。
核心结论
- 中国肝细胞腺瘤的临床和MRI表现有一定特异性,MR数据与基因型-表型分类间存在良好关系,ADC值可能为恶性转化的潜在指标。
研究设计与样本
- 回顾性研究,纳入36例患者共39个病理证实的肝细胞腺瘤,行钆喷酸葡胺增强MRI,评估T1、T2加权、动态增强及DWI特征,采用Kruskal-Wallis检验、Fisher精确检验和Dunn-Bonferroni事后检验比较四种亚型。
关键影像表现/征象
- T1和T2加权信号、强化方式和强度、病灶异质性在HCA亚型间不同(P<.0001至P=.019)。
- 伴随征象包括病灶脂肪变、坏死或囊性成分、中央瘢痕和假包膜在亚型间不同(P<.0001至P=.019)。
- β-catenin突变型HCA的ADC值最低,但事后比较各组间无显著差异(P=.066-1.000)。
诊断标准与关键数值
- ADC值在HCA亚型间整体不同(P=.029),β-catenin突变型ADC最低,但事后比较无显著差异(P=.066-1.000)。
临床应用与阅片要点
- 中国HCA患者男性多见(52.8%),均无口服避孕药史,16.7%合并乙肝感染,阅片时需注意这些临床特征。
- MRI信号、强化方式及伴随征象(脂肪变、坏死、中央瘢痕、假包膜)有助于区分HCA亚型。
- ADC值可能为恶性转化的潜在指标,但亚型间事后比较无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate and compare the MR features between hepatocellular adenoma (HCA) subtypes in China, including preliminary observations on diffusion-weighted imaging (DWI).
METHODS: Thirty-six patients with 39 pathologically proven HCAs underwent gadopentetate dimeglumine enhanced MRI. The morphological and imaging features on T1, T2-weighted, dynamic-enhanced imaging and DWI were retrospectively evaluated and compared between four HCA subtypes, using Kruskal-Wallis test, Fisher's exact test and Dunn-Bonferroni post hoc test.
RESULTS: HCA frequently occurred in male (n = 19, 52.8%), lacked an association with oral contraceptives (n = 0), and had a relatively high incidence of coexistent Hepatitis B infection (n = 6, 16.7%). Signals on T1 and T2-weighted imaging, enhancement pattern and intensity, lesion heterogeneity, as well as accompanying findings including lesion steatosis, necrosis or cystic component, central scar, and pseudocapsule were different between HCA subtypes (P < .0001 to P = .019). Apparent diffusion coefficient (ADC) values among HCA subtypes were different as a whole (P = .029), within which β-catenin-mutated HCA had the lowest ADCs; but post hoc comparisons demonstrated no significant differences between groups (P = .066-1.000).
CONCLUSION: Both clinical and MR imaging presentation of HCA in China had some specific characteristics, and a good relationship existed between MR data and genotype-phenotype classification. Furthermore, ADC value may provide a potential indicator of malignant transformation.
引用
- Wang H, Yang C, Rao S, et al. MR imaging of hepatocellular adenomas on genotype-phenotype classification: A report from China. Eur J Radiol. 2018. PMID: 29496071. doi:10.1016/j.ejrad.2018.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。